| Aug 19 |
Zacks Industry Outlook Highlights Corcept, Amneal, Bioventus, Foghorn and Akebia
|
| Aug 16 |
5 Small Drug Stocks to Buy as Innovation Reaches Peak
|
| Aug 12 |
Healing Numbers, Hurting Valuation: Bioventus' Mixed Bag In Q2 2024
|
| Aug 11 |
Bioventus Inc. (BVS) Q2 2024 Earnings Call Transcript
|
| Aug 7 |
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
|
| Aug 6 |
Bioventus reports Q2 results; raises guidance
|
| Aug 6 |
Bioventus Reports Second Quarter Financial Results
|
| Jul 30 |
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
|
| Jul 2 |
Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
|
| Jun 18 |
Compelling Reasons to Hold on to Cigna Stock for Now
|
